Ramsay Stattman Vela & Price’s Idexx Laboratories IDXX Stock Holding History

Ramsay Stattman Vela & Price’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.92M	Sell	3,656 -355	-9%	-$199K	0.34%	53
2026 Q1	$2.25M	Sell	4,011 -30	-0.7%	-$19.2K	0.45%	47
2025 Q4	$2.73M	Sell	4,041 -54	-1%	-$36.8K	0.49%	46
2025 Q3	$2.62M	Sell	4,095 -80	-2%	-$48.6K	0.47%	47
2025 Q2	$2.24M	Hold	4,175	–	–	0.42%	48
2025 Q1	$1.75M	Hold	4,175	–	–	0.33%	50
2024 Q4	$1.73M	Hold	4,175	–	–	0.32%	50
2024 Q3	$2.11M	Hold	4,175	–	–	0.39%	47
2024 Q2	$2.03M	Hold	4,175	–	–	0.38%	47
2024 Q1	$2.25M	Hold	4,175	–	–	0.43%	46
2023 Q4	$2.32M	Sell	4,175 -70	-2%	-$32.9K	0.47%	47
2023 Q3	$1.86M	Sell	4,245 -10	-0.2%	-$4.99K	0.4%	49
2023 Q2	$2.14M	Hold	4,255	–	–	0.44%	49
2023 Q1	$2.13M	Sell	4,255 -10	-0.2%	-$4.79K	0.46%	48
2022 Q4	$1.74M	Hold	4,265	–	–	0.39%	55
2022 Q3	$1.39M	Hold	4,265	–	–	0.34%	57
2022 Q2	$1.5M	Buy	4,265 +455	+12%	+$186K	0.34%	61
2022 Q1	$2.08M	Buy	+3,810	New	+$2M	0.41%	52

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ramsay Stattman Vela & Price's IDXX Position: Q2 2026 in Review

Ramsay Stattman Vela & Price reduced its Idexx Laboratories (IDXX) stake by 8.9% in Q2 2026, selling an estimated $199K and leaving 3,656 shares worth $1.92M. The position accounts for 0.34% of the portfolio, ranked #53.

Ramsay Stattman Vela & Price first reported a position in IDXX in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.73M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Ramsay Stattman Vela & Price held 3,656 shares of Idexx Laboratories worth $1.92M as of Q2 2026.
Ramsay Stattman Vela & Price sold 355 Idexx Laboratories shares in Q2 2026, an estimated $199K.
Idexx Laboratories made up 0.34% of Ramsay Stattman Vela & Price's portfolio in Q2 2026, its #53 holding.
Ramsay Stattman Vela & Price first reported a position in Idexx Laboratories in Q1 2022 and has held it in 18 quarters since.
Ramsay Stattman Vela & Price's Idexx Laboratories position peaked at $2.73M in Q4 2025.
1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ramsay Stattman Vela & Price's 13F filing for Q2 2026, filed 4 Aug 2026.